Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.1.68 CHF
Change Today 0.00 / 0.00%
Volume 1.2M
As of 12:43 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas Fulton Wilson McKillop Ph.D.

AgeTotal Calculated CompensationThis person is connected to 135 board members in 7 different organizations across 13 different industries.

See Board Relationships


Sir Thomas Fulton Wilson McKillop, also known as Tom, Ph.D., served as Chief Executive Officer of AstraZeneca PLC from 1999 to December 2005. Sir McKillop has more than 35 years of experience from management positions in the pharmaceutical industry. He served as Chief Executive Officer of Zeneca Pharmaceuticals from (also known as, Zeneca plc) 1994 to 1999. He held a number of senior and general management appointments with ICI before the demerger in 1993, when Zeneca ...

Read Full Background

Corporate Headquarters*

Duggingerstrasse 23
Reinach, Basel-Landschaft 4153


Phone: 41 61 485 20 00
Fax: 41 61 485 20 01

Board Members Memberships*

Former Chairman of the Board
Former Director
Former Executive Director
Former Director
Former Non-Executive Director, Member of Remuneration Committee, Member of Chairmans Committee and Member of Safety, Ethics & Environment Assurance Committee
Former Chairman, Deputy Chairman, Chairman of Nominations Committee and Member of Remuneration Committee
Former Director
Independent Director and Member of Governance, Nomination & Compensation Committee
Independent External Director and Chairman of Nominations & Remuneration Commission
Director and Member of Audit Committee


University of Glasgow Scotland
University of Glasgow Scotland

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options499,400
Unexercisable Options178,600
Total Number of Options678,000

Total Compensation*

Total Annual Cash CompensationSFr.43,200
Total Calculated CompensationSFr.80,900
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EVE:SW SFr.1.68 CHF 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EVOLVA HOLDING SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at